Typicality: | 0.429 |
Saliency: | 0.419 |
in the litigation | 8 | location |
therein | 5 | location |
against endo | 4 | transitive-object |
claim → be asserted against → the company | 52 |
claim → be asserted by → the company | 10 |
claim → be asserted by → company | 5 |
claim → be asserted against → company | 5 |
claim → be asserted against → your company | 3 |
negative | neutral | positive |
0.257 | 0.720 | 0.024 |
Raw frequency | 75 |
Normalized frequency | 0.419 |
Modifier score | 0.500 |
Perplexity | 290.613 |